Ajinomoto Co. AJNMY
—
32.28
0.76
2.41%
as of 25 Sep
- Market cap
- —
- P/E
- 39.8×
Follow AJNMY
Growth Flags
show if company had growth for consecutive years
| Older periods | Jun '25 | Sep '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
35.06 | — | — | 44.95 |
P/S ratio |
2.72 | — | — | 3.51 | |
P/FCF ratio |
20.05 | — | — | 46.28 | |
P/Operating CF |
127.06 | — | — | 300.27 | |
P/B ratio |
5.03 | — | — | 6.52 | |
Price to Tangible BV |
6.86 | — | — | 8.75 | |
EV/Sales |
2.89 | — | — | 3.63 | |
EV/EBITDA |
18.85 | — | — | 21.42 | |
EV/Operating CF |
11.37 | — | — | 19.80 | |
EV/FCF |
21.27 | — | — | 47.84 | |
Quick Ratio |
0.87 | 0.81 | 0.84 | 0.78 | |
Current Ratio |
1.59 | 1.62 | 1.51 | 1.45 | |
Net Debt/EBITDA |
3.34 | 0.00 | 0.00 | 2.35 | |
Debt/Assets |
25.66% | 25.59% | 23.56% | 21.74% | |
Debt/Equity |
0.58 | 0.57 | 0.55 | 0.50 | |
Asset Turnover |
0.79 | 0.00 | 0.00 | 0.83 | |
Operating CF/Net income |
0.94 | 0.00 | 0.00 | 0.51 | |
Capex/Depreciation |
(1.44) | (1.06) | (1.16) | (1.41) | |
Interest Coverage |
0.00 | — | — | 0.00 | |
Research and Development Expense of Revenue |
2.02% | — | — | 1.93% | |
Selling, General and Administrative Expense of Revenue |
24.05% | — | — | 24.08% | |
Intangible Assets out of Total Assets |
0.12 | 0.12 | 0.11 | 0.11 | |
Share Based Compensation of Revenue |
0.00% | — | — | 0.00% | |
Graham Net Nets |
(0.06) | — | — | (0.05) | |
Graham Number |
9.64 | — | — | 10.09 | |
Earnings Yield |
2.85% | — | — | 2.22% | |
Free Cash Flow Yield |
4.99% | — | — | 2.16% | |
Revenue per Share |
2.54 | — | — | 2.71 | |
Operating CF per Share |
0.21 | 0.00 | 0.00 | 0.12 | |
Capex per Share |
(0.21) | 0.00 | 0.00 | (0.22) | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | (0.10) | |
Cash per Share |
1.49 | 0.00 | 0.00 | 1.55 | |
Shareholders Equity per Share |
5.37 | 0.00 | 0.00 | 5.59 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.37 | 0.00 | 0.00 | 5.59 | |
Free Cash Flow |
0.99 | 269.52 | 574.05 | (92.06) | |
Working Capital |
1,881.10 | 1,842.55 | 1,783.17 | 1,622.69 | |
Capital Expenditures |
(208.90) | (154.61) | (494.32) | (208.03) | |
Net Current Asset Value |
(1,703.37) | (1,708.77) | (1,757.93) | (1,632.66) | |
EV/EBIT |
23.22 | — | — | 28.79 | |
Capex to Sales |
0.08 | 0.00 | 0.00 | 0.08 | |
Net Profit Margin |
8.85% | — | — | 8.85% | |
Price to Operating Income |
21.88 | — | — | 27.85 | |
| Other line items | |||||
Average Receivables |
1,403.38 | 1,305.55 | 1,403.66 | 1,320.90 | |
Average Payables |
1,526.67 | 1,572.85 | 1,616.22 | 1,633.83 | |
Average Inventory |
1,966.13 | 2,084.38 | 2,179.60 | 2,099.16 | |
Average Assets |
12,492.34 | 11,887.64 | 12,190.86 | 11,986.20 | |
Average Common Equity |
5,731.19 | 5,765.53 | 5,763.62 | 5,523.36 |
Columns are period end dates